Red blood cell distribution width is associated with increased interactions of blood cells with vascular wall.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
11 08 2022
Historique:
received: 26 01 2022
accepted: 02 08 2022
entrez: 11 8 2022
pubmed: 12 8 2022
medline: 16 8 2022
Statut: epublish

Résumé

The mechanism underlying the association between elevated red cell distribution width (RDW) and poor prognosis in variety of diseases is unknown although many researchers consider RDW a marker of inflammation. We hypothesized that RDW directly affects intravascular hemodynamics, interactions between circulating cells and vessel wall, inducing local changes predisposing to atherothrombosis. We applied different human and animal models to verify our hypothesis. Carotid plaques harvested from patients with high RDW had increased expression of genes and proteins associated with accelerated atherosclerosis as compared to subjects with low RDW. In microfluidic channels samples of blood from high RDW subjects showed flow pattern facilitating direct interaction with vessel wall. Flow pattern was also dependent on RDW value in mouse carotid arteries analyzed with Magnetic Resonance Imaging. In different mouse models of elevated RDW accelerated development of atherosclerotic lesions in aortas was observed. Therefore, comprehensive biological, fluid physics and optics studies showed that variation of red blood cells size measured by RDW results in increased interactions between vascular wall and circulating morphotic elements which contribute to vascular pathology.

Identifiants

pubmed: 35953533
doi: 10.1038/s41598-022-17847-z
pii: 10.1038/s41598-022-17847-z
pmc: PMC9366818
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13676

Informations de copyright

© 2022. The Author(s).

Références

Int J Mol Sci. 2020 Sep 15;21(18):
pubmed: 32942605
J Clin Invest. 1995 Aug;96(2):1145-51
pubmed: 7635951
Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1729-37
pubmed: 16741150
J Am Soc Nephrol. 2014 Aug;25(8):1669-78
pubmed: 24722450
Cardiovasc Res. 2005 Feb 1;65(2):535-45
pubmed: 15639493
Am J Hypertens. 2001 Jun;14(6 Pt 2):83S-89S
pubmed: 11411770
JAMA Netw Open. 2020 Sep 1;3(9):e2022058
pubmed: 32965501
Int J Gen Med. 2021 Nov 23;14:8667-8675
pubmed: 34849010
Microvasc Res. 1980 May;19(3):352-65
pubmed: 7382854
Biophys J. 2012 Oct 3;103(7):1604-15
pubmed: 23062353
Am J Physiol. 1993 Apr;264(4 Pt 2):H1239-44
pubmed: 8476101
J Vis Exp. 2015 Nov 03;(105):e53224
pubmed: 26554396
Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1271-9
pubmed: 23599443
Elife. 2019 Dec 17;8:
pubmed: 31845889
Opt Express. 2013 Oct 7;21(20):24025-38
pubmed: 24104312
Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1460-71
pubmed: 11009430
Microvasc Res. 1980 Jan;19(1):45-70
pubmed: 7360047
Appl Opt. 1997 Jan 1;36(1):144-9
pubmed: 18250655
Curr Opin Hematol. 2000 Mar;7(2):113-6
pubmed: 10698298
J Clin Invest. 2011 Oct;121(10):4043-55
pubmed: 21946257
Neurophotonics. 2020 Jan;7(1):015002
pubmed: 32016131
Ann Biomed Eng. 2008 Apr;36(4):534-44
pubmed: 18188702
Am J Physiol. 1992 Apr;262(4 Pt 2):H1217-23
pubmed: 1566903
Blood. 2013 May 2;121(18):3733-41
pubmed: 23343833
Biophys J. 2011 Oct 19;101(8):1835-43
pubmed: 22004736
J Biol Chem. 2009 May 8;284(19):13110-8
pubmed: 19276082
Front Cardiovasc Med. 2020 May 05;7:53
pubmed: 32478094
EBioMedicine. 2022 Feb;76:103816
pubmed: 35065420
Biophys J. 1995 Nov;69(5):2131-8
pubmed: 8580357
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18513-8
pubmed: 19017793
Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2608-17
pubmed: 23968981
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9473-9478
pubmed: 30190429
Comput Math Appl. 2008 Apr;55(7):1594-1600
pubmed: 19343080

Auteurs

Sharan Ananthaseshan (S)

Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden.

Krzysztof Bojakowski (K)

2nd Vascular Surgery and Angiology Department, Centre of Postgraduate Medical Education, Warsaw, Poland.

Mariusz Sacharczuk (M)

Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, 1a Banacha Street, 02-097, Warsaw, Poland.
Department of Experimental Genomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Jastrzebiec, Poland.

Piotr Poznanski (P)

Department of Experimental Genomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Jastrzebiec, Poland.

Dominik S Skiba (DS)

Department of Experimental Genomics, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Jastrzebiec, Poland.

Lisa Prahl Wittberg (L)

KTH Mechanics, Royal Institute of Technology, Stockholm, Sweden.

Jordan McKenzie (J)

KTH Mechanics, Royal Institute of Technology, Stockholm, Sweden.

Anna Szkulmowska (A)

AM2M Ltd. L.P., Torun, Poland.

Niclas Berg (N)

KTH Mechanics, Royal Institute of Technology, Stockholm, Sweden.

Piotr Andziak (P)

2nd Vascular Surgery and Angiology Department, Centre of Postgraduate Medical Education, Warsaw, Poland.

Hanna Menkens (H)

Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden.

Maciej Wojtkowski (M)

Institute of Physics, Nicolaus Copernicus University, Torun, Poland.

Dorota Religa (D)

NVS, Karolinska Institute, Stockholm, Sweden.

Fredrik Lundell (F)

KTH Mechanics, Royal Institute of Technology, Stockholm, Sweden.

Tomasz Guzik (T)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Zbigniew Gaciong (Z)

Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, 1a Banacha Street, 02-097, Warsaw, Poland. zgaciong@hotmail.com.

Piotr Religa (P)

Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden.
Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, 1a Banacha Street, 02-097, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH